Skin Microbiota – A Novel Target for Promoting Burn Wound Healing

Review article discussing
the wound microbiome and Amicapsil

Treatment of venous leg ulcers with Amicapsil

“Amicapsil healed my venous leg ulcers and changed my life.”

“From 4 weeks of absolute hell – to being pain-free, getting a full night’s sleep and back to normal at work.”

“From 4 weeks of absolute hell, in pain 24 hours a day, struggling at work – to being pain-free, getting a full night’s sleep and back to normal at work.”

NH ( patient)

SertaSil for veterinary wound treatment

SertaSil for veterinary wound care

Effective in treating severe infections, including infections not responding to antibiotics and antiseptics.

Treatment of wounds and pressure ulcers in persons with spinal cord injury

Amicapsil-SCI

Effective treatment of wounds and pressure ulcers in SCI-persons and in controlling soft tissue infection caused by osteomyelitis.

Amicapsil and Amicapsil-SCI on NHS Supply Chain

From September 1, 2025, Amicapsil and Amicapsil SCI are now on NHS Supply Chain. They are included in the category Medical Surgical Rehabilitation & Community, as part of the Advanced Wound Care framework. They can be ordered by via the standard NHS ordering system.

For more information, please see the NHS-page.

MPPT is available as:

Wounds, ulcers and burns

Amicapsil for humans

Trauma and surgical wounds, pressure ulcers, venous leg ulcers, diabetic foot ulcers, burns, etc.

SertaSil for animals

Trauma and surgical wounds, abscesses, amputations, and burns in dogs, horses and other animals.

Dermatology

Aprobaxil for humans

Acne, pyoderma gangrenosum, hidradenitis suppurativa, atopic dermatitis, zits etc

Adinasil for animals

Eczema, dermatitis, lick granuloma, insect bites, autoimmune skin conditions, etc.

July 15’th, 2025 – New analysis published in Frontiers in Public Health questions whether antimicrobials play a major role in causing climate change.

New publication in Frontiers in Public Health: The contribution of antimicrobials and antimicrobial resistance to climate change and a possible

June 20’th, 2024 – Patient survey of MPPT published in Frontiers in Rehabilitation Sciences

The British Spinal Injuries Association SIA has published a user-survey in Frontiers in Rehabilitation Sciences: Patient-reported outcome survey of user-experiences

Amicapsil and Amicapsil-SCI on NHS Supply Chain

MPPT is available as:

Wounds, ulcers and burns

Amicapsil for humans

SertaSil for animals

Dermatology

Aprobaxil for humans

Adinasil for animals

Related Posts

July 15’th, 2025 – New analysis published in Frontiers in Public Health questions whether antimicrobials play a major role in causing climate change.

June 20’th, 2024 – Patient survey of MPPT published in Frontiers in Rehabilitation Sciences

Amicapsil and Amicapsil-SCI on NHS Supply Chain

July 15’th, 2025 – New analysis published in Frontiers in Public Health questions whether antimicrobials play a major role in causing climate change.

June 20’th, 2024 – Patient survey of MPPT published in Frontiers in Rehabilitation Sciences

January 5’th, 2024 – MPPT clinical study published in Frontiers in Medicine